KEMPHARM, INC (KMPH) News Headlines

▮ More

Date

Headline

5/19/2020 7:35:44 AM KemPharm Receives Day-74 Letter For KP415 NDA; FDA Sets PDUFA Date Of March 2, 2021

2/28/2020 7:35:20 AM KemPharm Q4 Net Loss $6.0 Mln Or $0.18 Per Share

12/18/2019 7:25:58 AM KemPharm Reports Debt Restructuring With Deerfield And Delaware Street Capital

8/5/2019 9:46:46 PM 5 Top Gainers In Healthcare Sector (ALLK, IMGN, LXRX...)

5/20/2019 10:21:44 PM 5 Top Gainers In Pharma Sector (OTLK, SESN, UROV...)

1/29/2019 7:36:04 AM KemPharm Says Enhancements To U.S. And Global Intellectual Property Estate; Patents Extend Across Prodrug Portfolio

1/18/2019 7:33:26 AM KemPharm Presents Four Scientific Posters At APSARD's 2019 Annual Meeting

1/7/2019 7:38:54 AM KemPharm Says FDA Approves SNDA For Two Additional Strengths Of APADA

10/5/2018 9:29:06 AM KemPharm Prices Public Offering Of 8.33 Mln Common Shares At $3.00 Per Share

10/4/2018 4:08:27 PM KemPharm Announces Proposed Public Offering Of Common Stock

9/17/2018 7:33:48 AM KemPharm Announces Positive Topline Results From Intranasal Human Abuse Potential Trial Of KP415 Prodrug

9/12/2018 2:28:34 AM FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct.

9/11/2018 7:31:15 AM KemPharm Announces Positive Topline Results From Oral Human Abuse Potential Trial Of KP415 Prodrug

7/13/2018 7:56:09 PM Week Ahead In Pharmaceuticals - 7 Stocks To Watch

7/10/2018 2:39:24 AM ISR Soars On FDA Nod For GammaTile, KMPH On Watch, Investors Believe In XLRN

7/7/2018 11:03:29 AM Week Ahead In Pharmaceuticals - Stocks To Watch

5/11/2018 1:11:45 AM BLFS Q1 Revenue Up 61%, VRAY Garners Attention, AKCA Gets FDA Panel Nod

3/21/2018 8:52:08 PM GERN Turning Heads, ARQL To Present Data In Apr., Mark Your Calendar For PTN

3/21/2018 3:26:40 AM FDA Nod For SGEN's Adcetris, Antibe Soars On GI Data, CHMA Empowered

3/20/2018 7:33:43 AM KemPharm Announces Positive Topline Results From KP415 Pharmacokinetic Study In Children And Adolescents With ADHD

Kempharm, Inc (KMPH)